The primary goal of the Morphology Core Laboratory is to serve as a centralized, on-site resource to facilitate performance of morphologic, immunohistochemical, ultrastructural and morphometric studies needed for the proposed projects. This Core provides access to state-of-the-art instrumentation, technical assistance, instruction and consultation for PPG investigators conducting cell biological and morphologic studies at the cellular and ultrastructural level. Major equipment maintained within the Core includes a full range of light, confocal and electron microscopes; ancillary apparatus and preparative resources; as well as hardware and software for computer-assisted image, morphometric and densitometric analyses. The laboratory is staffed by well-qualified, experienced technicians, who will process tissues for light and transmission electron microscopy, including immunohistochemistry. Two members of the Core technical staff have received certification as histologists by the American Society of Clinical Pathologists. All procedures are standardized using written Standard Operating Procedures. All of the proposed projects will rely substantially on the resources available in this unit.
The Specific Aims of this service core are to: 1) Prepare high-quality histologic sections for PPG investigators. 2) Provide access to a full range of optical instrumentation for morphologic investigation including light, confocal and electron microscopes; preparative devices; photographic equipment; CCD camera; and computer based image analysis, morphometry, and densitometry. 3) Provide technical assistance in all routine aspects of light and electron microscopy, specimen processing, computer assisted image analysis, morphometry, densitometry, and processing of images and micrographs. 4) Provide instruction in the use of instrumentation and consultation on experimental design, with specialized cytological and ultrastructural methods pertinent to particular projects. 5) Assist with development of new approaches to morphologic and morphometric analyses. 6) Perform toxicology studies according to GLP protocol required for pre-clinical studies to support applications for research permits from the FDA.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
1P01HL066973-01A1
Application #
6533344
Study Section
Heart, Lung, and Blood Program Project Review Committee (HLBP)
Project Start
2001-09-30
Project End
2006-07-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2001
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Monahan, Paul E; Sun, Junjiang; Gui, Tong et al. (2015) Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trial. Hum Gene Ther 26:69-81
Monahan, P E (2015) Gene therapy in an era of emerging treatment options for hemophilia B. J Thromb Haemost 13 Suppl 1:S151-60
Piacentino 3rd, Valentino; Milano, Carmelo A; Bolanos, Michael et al. (2012) X-linked inhibitor of apoptosis protein-mediated attenuation of apoptosis, using a novel cardiac-enhanced adeno-associated viral vector. Hum Gene Ther 23:635-46
Kantor, Boris; Bayer, Matthew; Ma, Hong et al. (2011) Notable reduction in illegitimate integration mediated by a PPT-deleted, nonintegrating lentiviral vector. Mol Ther 19:547-56
Cockrell, Adam S; van Praag, Henriette; Santistevan, Nicholas et al. (2011) The HIV-1 Rev/RRE system is required for HIV-1 5' UTR cis elements to augment encapsidation of heterologous RNA into HIV-1 viral particles. Retrovirology 8:51
Monahan, Paul E; Lothrop, Clinton D; Sun, Junjiang et al. (2010) Proteasome inhibitors enhance gene delivery by AAV virus vectors expressing large genomes in hemophilia mouse and dog models: a strategy for broad clinical application. Mol Ther 18:1907-16
Li, C; Hirsch, M; Carter, P et al. (2009) A small regulatory element from chromosome 19 enhances liver-specific gene expression. Gene Ther 16:43-51
Gui, T; Reheman, A; Ni, H et al. (2009) Abnormal hemostasis in a knock-in mouse carrying a variant of factor IX with impaired binding to collagen type IV. J Thromb Haemost 7:1843-51
Li, Chengwen; Goudy, Kevin; Hirsch, Matt et al. (2009) Cellular immune response to cryptic epitopes during therapeutic gene transfer. Proc Natl Acad Sci U S A 106:10770-4
Kantor, Boris; Ma, Hong; Webster-Cyriaque, Jennifer et al. (2009) Epigenetic activation of unintegrated HIV-1 genomes by gut-associated short chain fatty acids and its implications for HIV infection. Proc Natl Acad Sci U S A 106:18786-91

Showing the most recent 10 out of 38 publications